Clinical Drug Investigation

, Volume 24, Issue 7, pp 427–429 | Cite as

Verrucous Psoriasis in a Patient with Chronic C Hepatitis Treated with Interferon

  • Sebastiano Scavo
  • Alessandra Gurrera
  • Claudio Mazzaglia
  • Gaetano Magro
  • Davide Pulvirenti
  • Erika Gozzo
  • Sergio Neri
Case Report

Keywords

Psoriasis Vitiligo Natural Killer Receptor Normalise Transaminase Level Elevated Serum Iron 

Notes

Acknowledgements

This work was partly supported by a grant from the Italian University Ministry. The authors are indebted to Ms Moira Macpherson for her assistance in translating this paper.

References

  1. 1.
    EASL International Consensus Conference on Hepatitis C. Paris 26–28 Feb 1999. J Hepatol 1999; 30: 956–61CrossRefGoogle Scholar
  2. 2.
    Asnis LA, Gaspari AA. Cutaneous reactions to recombinant cytokine therapy. J Am Acad Dermatol 1995; 33: 393–410PubMedCrossRefGoogle Scholar
  3. 3.
    Paquet P, Pierard-Franchimont C, Arrese JE, et al. Cutaneous side effects of interferon. Rev Med Liege 2001 Oct; 56(10): 699–702PubMedGoogle Scholar
  4. 4.
    Raani P, Ben-Bassat I. Immune mediated complications during interferon therapy in haematological patients. Acta Haematol 2002; 107(3): 133–44CrossRefGoogle Scholar
  5. 5.
    Knodell RG, Ishak KG, Black WC, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1981; 1(5): 431–5PubMedCrossRefGoogle Scholar
  6. 6.
    Gilhar A, Ullmann Y, Kerner H, et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002 Aug; 119(2): 384–91PubMedCrossRefGoogle Scholar
  7. 7.
    Yamamoto T, Nishioka K. Oral psoriasis in a patient with hepatitis C virus infection. Eur J Dermatol 2002; 12: 75–6PubMedGoogle Scholar
  8. 8.
    8. Ong PY, Hamid QA, Travers JB, et al. Decreased IL-15 may contribute to elevated IgE and acute inflammation in atopic dermatitis. J Immunol 2002 Jan 1; 168(1): 505–10PubMedGoogle Scholar
  9. 9.
    Hardman JG, Limbird LE, Gilman AG. Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. Maidenhead, Berks: McGraw-Hill 2001Google Scholar
  10. 10.
    Lombardini F, Tallione E, Riente L, et al. Psoriatic arthritis with spinal involvement in a patient receiving α-interferon for chronic hepatitis C. Scand J Rheumatol 1997; 26(1): 58–60PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2004

Authors and Affiliations

  • Sebastiano Scavo
    • 1
  • Alessandra Gurrera
    • 2
  • Claudio Mazzaglia
    • 3
  • Gaetano Magro
    • 2
  • Davide Pulvirenti
    • 2
  • Erika Gozzo
    • 1
  • Sergio Neri
    • 3
  1. 1.Department of DermatologyCatania UniversityCataniaItaly
  2. 2.Department of PathologyCatania UniversityCataniaItaly
  3. 3.Department of Internal Medicine, Ospedale S. MartaCatania UniversityCataniaItaly

Personalised recommendations